Next Article in Journal
Longitudinal Consumption of Ergothioneine Reduces Oxidative Stress and Amyloid Plaques and Restores Glucose Metabolism in the 5XFAD Mouse Model of Alzheimer’s Disease
Next Article in Special Issue
Opportunities and Challenges for In Silico Drug Discovery at Delta Opioid Receptors
Previous Article in Journal
Rational Design by Structural Biology of Industrializable, Long-Acting Antihyperglycemic GLP-1 Receptor Agonists
Previous Article in Special Issue
In Silico Antiprotozoal Evaluation of 1,4-Naphthoquinone Derivatives against Chagas and Leishmaniasis Diseases Using QSAR, Molecular Docking, and ADME Approaches
 
 
Article

Article Versions Notes

Pharmaceuticals 2022, 15(6), 741; https://doi.org/10.3390/ph15060741
Action Date Notes Link
article xml file uploaded 13 June 2022 11:46 CEST Original file -
article xml uploaded. 13 June 2022 11:46 CEST Update -
article pdf uploaded. 13 June 2022 11:46 CEST Version of Record https://www.mdpi.com/1424-8247/15/6/741/pdf-vor
article html file updated 13 June 2022 11:48 CEST Original file -
article xml file uploaded 23 June 2022 03:25 CEST Update -
article xml uploaded. 23 June 2022 03:25 CEST Update -
article pdf uploaded. 23 June 2022 03:25 CEST Updated version of record https://www.mdpi.com/1424-8247/15/6/741/pdf-vor
article html file updated 23 June 2022 03:27 CEST Update -
article xml file uploaded 23 June 2022 08:41 CEST Update -
article xml uploaded. 23 June 2022 08:41 CEST Update https://www.mdpi.com/1424-8247/15/6/741/xml
article pdf uploaded. 23 June 2022 08:41 CEST Updated version of record https://www.mdpi.com/1424-8247/15/6/741/pdf
article html file updated 23 June 2022 08:43 CEST Update -
article html file updated 12 August 2022 20:06 CEST Update https://www.mdpi.com/1424-8247/15/6/741/html
Back to TopTop